Inflammatory Cardiomyopathy clinical trials

Explore recruiting inflammatory cardiomyopathy clinical trials.

Recruiting inflammatory cardiomyopathy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Inflammatory Cardiomyopathy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Single-blinded randomized investigator-initiated controlled trial to assess the efficacy of colchicine to treat patients with cardiomyopathy with myocarditis (chronic inflammatory cardiomyopathy) – Trial and Registry to study the role of genotype environment interaction in Chronic myocarditis and inflammatory cardiomyopathies with ventricular pro-arrhythmic and heart failure phenotypes (PNRR-MAD-2022-12376225)

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of immunosuppression in biopsy-proven virus-negative myocarditis or inflammatory cardiomyopathy (IMPROVE-MC).

Poland

Therapeutic use (Phase IV) EU CTIS Study details

A multicenter, randomized, double-blind, placebo-controlled TRial evaluating Immunosuppressive treatment in patients with chronic virus-Negative Inflammatory cardiomyopaThY (TRINITY trial)

Germany

Phase II and Phase III (Integrated) EU CTIS Study details

Inflammatory Cardiomyopathy trials by city

Inflammatory Cardiomyopathy in Toronto Inflammatory Cardiomyopathy in Vancouver Inflammatory Cardiomyopathy in Montreal Inflammatory Cardiomyopathy in Calgary Inflammatory Cardiomyopathy in Edmonton Inflammatory Cardiomyopathy in Ottawa Inflammatory Cardiomyopathy in Winnipeg Inflammatory Cardiomyopathy in Quebec City Inflammatory Cardiomyopathy in Hamilton Inflammatory Cardiomyopathy in Kitchener Inflammatory Cardiomyopathy in London Inflammatory Cardiomyopathy in Halifax Inflammatory Cardiomyopathy in New York Inflammatory Cardiomyopathy in Los Angeles Inflammatory Cardiomyopathy in Chicago Inflammatory Cardiomyopathy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease